...
机译:胰头腺癌的治疗策略的成本效益和潜在的改善机会
Department of Surgery, University of Cincinnati, Cincinnati, OH, USA;
Surgical Outcomes and Quality Improvement Center, Department of Surgery, and Northwestern Institute for Comparative Effectiveness Research in Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA;
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
Surgical Outcomes and Quality Improvement Center, Department of Surgery, and Northwestern Institute for Comparative Effectiveness Research in;
机译:胰头腺癌治疗策略的成本效益和潜在的改善机会
机译:原发性可手术性胰头腺癌治疗策略的成本效益:我们是否有更多科学证据要求进一步集中治疗?
机译:原发性可手术性胰头腺癌治疗策略的成本效益:我们是否有更多科学证据要求进一步集中治疗?
机译:使用谐波运动成像(HMI)在体内和在手术后的人类标本中检测胰管腺癌的方法和治疗监测
机译:与颅底可重型胰腺腺癌患者的痛苦治疗相比,胰腺切除术治疗中位生存率是否增加了胰腺的头部胰腺炎的患者?
机译:治疗胰腺癌的改善空间:来自基因靶向治疗的新机遇
机译:成像在胰腺癌目前治疗策略中的作用